The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
Objective To summarise how costs and health benefits will change with the adoption of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer. Design Cost-effectiveness modelling using the information from a randomised controlled t...
Gespeichert in:
Veröffentlicht in: | BMJ open 2013-01, Vol.3 (4), p.e001884 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | e001884 |
container_title | BMJ open |
container_volume | 3 |
creator | Graves, Nicholas Janda, Monika Merollini, Katharina Gebski, Val Obermair, Andreas |
description | Objective To summarise how costs and health benefits will change with the adoption of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer. Design Cost-effectiveness modelling using the information from a randomised controlled trial. Participants Two hypothetical modelled cohorts of 1000 individuals undergoing total laparoscopic hysterectomy and total abdominal hysterectomy. Outcome measures Surgery costs; hospital bed days used; total healthcare costs; quality-adjusted life years; and net monetary benefits. Results For 1000 individuals receiving total laparoscopic hysterectomy surgery, the costs were $509 575 higher, 3548 hospital fewer bed days were used and total health services costs were reduced by $3 746 221. There were 39.13 more quality-adjusted life years for a 5 year period following surgery. Conclusions The adoption of total laparoscopic hysterectomy is almost certainly a good decision for health services policy makers. There is 100% probability that it will be cost saving to health services, a 86.8% probability that it will increase health benefits and a 99.5% chance that it returns net monetary benefits greater than zero. |
doi_str_mv | 10.1136/bmjopen-2012-001884 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3641468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4031452281</sourcerecordid><originalsourceid>FETCH-LOGICAL-b472t-d8e7535c2b5a24ed55f6752d68ea5963be07c18e804b82044f82745c5524ba903</originalsourceid><addsrcrecordid>eNqNkc1q3DAUhUVoSIYkTxAohm66cap_y5tCGdIfCHSTrIUsX2c82JYraQbmRfK8ucNMQ6araqML9ztHV_cQcsvoHWNCf2nGdZhhKjllvKSUGSPPyIJTKUtNlfrwrr4kNymtKR6paqX4BbnkQlMppFqQl8cVFD6kXELXgc_9FiZIqQhdkUN2QzG42cWQfJh7X6x2KUNELIw7VI3YghbBI-uaNoz9hNUJ2IVYZHwmR3B5hCnv3cHFYVek7J6hgAl1kGOPSu8mD_GanHduSHBzvK_I0_f7x-XP8uH3j1_Lbw9lIyuey9ZApYTyvFGOS2iV6nSleKsNOFVr0QCtPDNgqGzMfiGd4ZVUHrcgG1dTcUW-HnznTTNC63G46AY7x350cWeD6-1pZ-pX9jlsrdCSSW3Q4PPRIIY_G0jZjn3yMAxugrBJlglhRM2oZoh--gddh03EbSFVGaF4VUuJlDhQHreeInRvwzBq99HbY_R2H709RI-qj-__8ab5GzQCdwcA1f_l-AoXGb5t</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1783527944</pqid></control><display><type>article</type><title>The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer</title><source>BMJ Open Access Journals</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Graves, Nicholas ; Janda, Monika ; Merollini, Katharina ; Gebski, Val ; Obermair, Andreas</creator><creatorcontrib>Graves, Nicholas ; Janda, Monika ; Merollini, Katharina ; Gebski, Val ; Obermair, Andreas ; LACE trial committee ; for the LACE trial committee</creatorcontrib><description>Objective To summarise how costs and health benefits will change with the adoption of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer. Design Cost-effectiveness modelling using the information from a randomised controlled trial. Participants Two hypothetical modelled cohorts of 1000 individuals undergoing total laparoscopic hysterectomy and total abdominal hysterectomy. Outcome measures Surgery costs; hospital bed days used; total healthcare costs; quality-adjusted life years; and net monetary benefits. Results For 1000 individuals receiving total laparoscopic hysterectomy surgery, the costs were $509 575 higher, 3548 hospital fewer bed days were used and total health services costs were reduced by $3 746 221. There were 39.13 more quality-adjusted life years for a 5 year period following surgery. Conclusions The adoption of total laparoscopic hysterectomy is almost certainly a good decision for health services policy makers. There is 100% probability that it will be cost saving to health services, a 86.8% probability that it will increase health benefits and a 99.5% chance that it returns net monetary benefits greater than zero.</description><identifier>ISSN: 2044-6055</identifier><identifier>EISSN: 2044-6055</identifier><identifier>DOI: 10.1136/bmjopen-2012-001884</identifier><identifier>PMID: 23604345</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Abdomen ; Cancer therapies ; Cost analysis ; Dissection ; Endometrial cancer ; Gynecology ; Health Economics ; Health services ; Hospitals ; Hysterectomy ; Laparoscopy ; Laparotomy ; Length of stay ; Lymphatic system ; Medicare ; Mortality ; Nursing ; Oncology ; Surgeons ; Surgery ; Surgical outcomes ; Uterine cancer</subject><ispartof>BMJ open, 2013-01, Vol.3 (4), p.e001884</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2013 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b472t-d8e7535c2b5a24ed55f6752d68ea5963be07c18e804b82044f82745c5524ba903</citedby><cites>FETCH-LOGICAL-b472t-d8e7535c2b5a24ed55f6752d68ea5963be07c18e804b82044f82745c5524ba903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmjopen.bmj.com/content/3/4/e001884.full.pdf$$EPDF$$P50$$Gbmj$$Hfree_for_read</linktopdf><linktohtml>$$Uhttp://bmjopen.bmj.com/content/3/4/e001884.full$$EHTML$$P50$$Gbmj$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27549,27550,27924,27925,53791,53793,77601,77632</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23604345$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Graves, Nicholas</creatorcontrib><creatorcontrib>Janda, Monika</creatorcontrib><creatorcontrib>Merollini, Katharina</creatorcontrib><creatorcontrib>Gebski, Val</creatorcontrib><creatorcontrib>Obermair, Andreas</creatorcontrib><creatorcontrib>LACE trial committee</creatorcontrib><creatorcontrib>for the LACE trial committee</creatorcontrib><title>The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer</title><title>BMJ open</title><addtitle>BMJ Open</addtitle><description>Objective To summarise how costs and health benefits will change with the adoption of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer. Design Cost-effectiveness modelling using the information from a randomised controlled trial. Participants Two hypothetical modelled cohorts of 1000 individuals undergoing total laparoscopic hysterectomy and total abdominal hysterectomy. Outcome measures Surgery costs; hospital bed days used; total healthcare costs; quality-adjusted life years; and net monetary benefits. Results For 1000 individuals receiving total laparoscopic hysterectomy surgery, the costs were $509 575 higher, 3548 hospital fewer bed days were used and total health services costs were reduced by $3 746 221. There were 39.13 more quality-adjusted life years for a 5 year period following surgery. Conclusions The adoption of total laparoscopic hysterectomy is almost certainly a good decision for health services policy makers. There is 100% probability that it will be cost saving to health services, a 86.8% probability that it will increase health benefits and a 99.5% chance that it returns net monetary benefits greater than zero.</description><subject>Abdomen</subject><subject>Cancer therapies</subject><subject>Cost analysis</subject><subject>Dissection</subject><subject>Endometrial cancer</subject><subject>Gynecology</subject><subject>Health Economics</subject><subject>Health services</subject><subject>Hospitals</subject><subject>Hysterectomy</subject><subject>Laparoscopy</subject><subject>Laparotomy</subject><subject>Length of stay</subject><subject>Lymphatic system</subject><subject>Medicare</subject><subject>Mortality</subject><subject>Nursing</subject><subject>Oncology</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Uterine cancer</subject><issn>2044-6055</issn><issn>2044-6055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>ACMMV</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkc1q3DAUhUVoSIYkTxAohm66cap_y5tCGdIfCHSTrIUsX2c82JYraQbmRfK8ucNMQ6araqML9ztHV_cQcsvoHWNCf2nGdZhhKjllvKSUGSPPyIJTKUtNlfrwrr4kNymtKR6paqX4BbnkQlMppFqQl8cVFD6kXELXgc_9FiZIqQhdkUN2QzG42cWQfJh7X6x2KUNELIw7VI3YghbBI-uaNoz9hNUJ2IVYZHwmR3B5hCnv3cHFYVek7J6hgAl1kGOPSu8mD_GanHduSHBzvK_I0_f7x-XP8uH3j1_Lbw9lIyuey9ZApYTyvFGOS2iV6nSleKsNOFVr0QCtPDNgqGzMfiGd4ZVUHrcgG1dTcUW-HnznTTNC63G46AY7x350cWeD6-1pZ-pX9jlsrdCSSW3Q4PPRIIY_G0jZjn3yMAxugrBJlglhRM2oZoh--gddh03EbSFVGaF4VUuJlDhQHreeInRvwzBq99HbY_R2H709RI-qj-__8ab5GzQCdwcA1f_l-AoXGb5t</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Graves, Nicholas</creator><creator>Janda, Monika</creator><creator>Merollini, Katharina</creator><creator>Gebski, Val</creator><creator>Obermair, Andreas</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130101</creationdate><title>The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer</title><author>Graves, Nicholas ; Janda, Monika ; Merollini, Katharina ; Gebski, Val ; Obermair, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b472t-d8e7535c2b5a24ed55f6752d68ea5963be07c18e804b82044f82745c5524ba903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Abdomen</topic><topic>Cancer therapies</topic><topic>Cost analysis</topic><topic>Dissection</topic><topic>Endometrial cancer</topic><topic>Gynecology</topic><topic>Health Economics</topic><topic>Health services</topic><topic>Hospitals</topic><topic>Hysterectomy</topic><topic>Laparoscopy</topic><topic>Laparotomy</topic><topic>Length of stay</topic><topic>Lymphatic system</topic><topic>Medicare</topic><topic>Mortality</topic><topic>Nursing</topic><topic>Oncology</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Uterine cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Graves, Nicholas</creatorcontrib><creatorcontrib>Janda, Monika</creatorcontrib><creatorcontrib>Merollini, Katharina</creatorcontrib><creatorcontrib>Gebski, Val</creatorcontrib><creatorcontrib>Obermair, Andreas</creatorcontrib><creatorcontrib>LACE trial committee</creatorcontrib><creatorcontrib>for the LACE trial committee</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Graves, Nicholas</au><au>Janda, Monika</au><au>Merollini, Katharina</au><au>Gebski, Val</au><au>Obermair, Andreas</au><aucorp>LACE trial committee</aucorp><aucorp>for the LACE trial committee</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer</atitle><jtitle>BMJ open</jtitle><addtitle>BMJ Open</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>3</volume><issue>4</issue><spage>e001884</spage><pages>e001884-</pages><issn>2044-6055</issn><eissn>2044-6055</eissn><abstract>Objective To summarise how costs and health benefits will change with the adoption of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer. Design Cost-effectiveness modelling using the information from a randomised controlled trial. Participants Two hypothetical modelled cohorts of 1000 individuals undergoing total laparoscopic hysterectomy and total abdominal hysterectomy. Outcome measures Surgery costs; hospital bed days used; total healthcare costs; quality-adjusted life years; and net monetary benefits. Results For 1000 individuals receiving total laparoscopic hysterectomy surgery, the costs were $509 575 higher, 3548 hospital fewer bed days were used and total health services costs were reduced by $3 746 221. There were 39.13 more quality-adjusted life years for a 5 year period following surgery. Conclusions The adoption of total laparoscopic hysterectomy is almost certainly a good decision for health services policy makers. There is 100% probability that it will be cost saving to health services, a 86.8% probability that it will increase health benefits and a 99.5% chance that it returns net monetary benefits greater than zero.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>23604345</pmid><doi>10.1136/bmjopen-2012-001884</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2044-6055 |
ispartof | BMJ open, 2013-01, Vol.3 (4), p.e001884 |
issn | 2044-6055 2044-6055 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3641468 |
source | BMJ Open Access Journals; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Abdomen Cancer therapies Cost analysis Dissection Endometrial cancer Gynecology Health Economics Health services Hospitals Hysterectomy Laparoscopy Laparotomy Length of stay Lymphatic system Medicare Mortality Nursing Oncology Surgeons Surgery Surgical outcomes Uterine cancer |
title | The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A57%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20cost-effectiveness%20of%20total%20laparoscopic%20hysterectomy%20compared%20to%20total%20abdominal%20hysterectomy%20for%20the%20treatment%20of%20early%20stage%20endometrial%20cancer&rft.jtitle=BMJ%20open&rft.au=Graves,%20Nicholas&rft.aucorp=LACE%20trial%20committee&rft.date=2013-01-01&rft.volume=3&rft.issue=4&rft.spage=e001884&rft.pages=e001884-&rft.issn=2044-6055&rft.eissn=2044-6055&rft_id=info:doi/10.1136/bmjopen-2012-001884&rft_dat=%3Cproquest_pubme%3E4031452281%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1783527944&rft_id=info:pmid/23604345&rfr_iscdi=true |